PDF herunterladen
Suchttherapie 2005; 6(3): 133-136
DOI: 10.1055/s-2005-858616
Kasuistik

© Georg Thieme Verlag KG Stuttgart · New York

ADHS und Sucht: erste Erfahrungen in der Behandlung mit Atomoxetin

ADHDS and Addiction: First Experimences from the Treatment with AtomoxetineC. Haasen1 , T. Fink1 , I. Schäfer1 , J. Reimer1
  • 1Suchtambulanz, Klinik für Psychiatrie u. Psychotherapie, Universitätsklinikum Hamburg-Eppendorf
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. September 2005 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Zusammenfassung

ADHS im Erwachsenenalter ist mit einem erhöhten Risiko der Entwicklung einer Suchstörung assoziiert. Wegen dem Suchtpotential von Methylphenidat wird die Behandlung mit Atomoxetin bei Suchtpatienten mit ADHS diskutiert. Anhang von zwei Fällen werden erste Erfahrungen beschrieben. Zukünftige Studien auch bezüglich der Dosierung sind notwendig.

Abstract

The adult form of ADHD is associated with a higher risk of developing a substance use disorder (SUD). Due to the addictive potential of methylphenidate, treatment with atomoxetine is discussed for patients with SUD and ADHD, and two cases are presented. Future studies, also with regard to dosage, are needed.

Schlüsselwörter

ADHS - Atomoxetin - Sucht

Key words

ADHD - atomoxetine - addiction

Literatur

  • 1 Spencer T. Is attention-deficit hyperactivity disorder in adults a valid disorder?.  Harvard Rev Psychiatry. 1994;  1 326-335
    PubMedGoogle Scholar
  • 2 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington DC; APP 1987
    Google Scholar
  • 3 Krause K H, Krause J, Trott G E. Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung) im Erwachsenenalter.  Nervenarzt. 1998;  69 543-556
    CrossrefPubMedGoogle Scholar
  • 4 Wender P H. The diagnosis and treatment of attention-deficit hyperactivity disorder in adults. Dunner DL Current psychiatric therapy Philadelphia, London, Toronto; Saunders 1993: 489-493
    Google Scholar
  • 5 American Psychiatric Association .Diagnostic and statistical manual of mental disorders (DSM IV). Washington DC; APP 1994
    Google Scholar
  • 6 Manuzza S, Klein R G, Bessler A. et al . Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.  Arch Gen Psychiatry. 1993;  50 565-567
    PubMedGoogle Scholar
  • 7 Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.  J Am Acad Child Adolesc Psychiatry. 2000;  39 1424-1431
    CrossrefPubMedGoogle Scholar
  • 8 Steinhausen H C. Attention-deficit hyperactivity disorder in a life perspective.  Acta Psych Scand. 2003;  107 321-322
    PubMedGoogle Scholar
  • 9 Weiss G, Hechtman L, Milroy T. et al . Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.  J Am Acad Child Adolesc Psychiatry. 1985;  24 211-223
    PubMedGoogle Scholar
  • 10 Barkley R A. Attention deficit hyperactivity disorder: long term course, adult outcome, and comorbid disorder. NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Disorder. Washington DC; NIH-Press 1998: 57-59
    Google Scholar
  • 11 Krause J, Krause K H. ADHS im Erwachsenenalter. Die Aufmerksamkeits-/Hyperaktivitätsstörung bei Erwachsenen. Stuttgart, New York; Schattauer 2003
    Google Scholar
  • 12 Retz-Junginger P, Retz W, Blocher D. et al . Wender Utah Rating Scale (WURS-k).  Nervenarzt. 2002;  73 830-838
    CrossrefPubMedGoogle Scholar
  • 13 Rösler M, Retz W, Retz-Junginger P. et al . Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter.  Nervenarzt. 2004;  75 888-895
    Google Scholar
  • 14 Conners C K, Erhardt D, Sparrow E. Conner’s Adult ADHD Rating Scales (CAARS). North Tonawanda, NY; Multi-Health Systems 1999
    Google Scholar
  • 15 Brown T E. Brown attention deficit disorder scales. San Antonio, TX; Psychol Corp 1996
    Google Scholar
  • 16 Kessler R C, Adler L, Ames M. et al . The World Health Organisation adult ADHD self-report scale (ASRS): a short screening scale for use in the general population.  Psychol Medicine. 2005;  35 245-256
    PubMedGoogle Scholar
  • 17 Manuzza S. et al . Hyperactive boys almost grown up: V. Replication of psychiatric status.  Arch Gen Psychiatry. 1991;  48 77-83
    PubMedGoogle Scholar
  • 18 Wilens T. et al . Comorbidity of attention deficit hyperactivity and psychoactive substance use disorder.  Hosp Commun Psychiatry. 1994;  45 421-435
    PubMedGoogle Scholar
  • 19 Schubiner H, Tzelepis A, Milberger S. et al . Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.  J Clin Psychiatry. 2000;  61 244-251
    CrossrefPubMedGoogle Scholar
  • 20 Wilens T E. AOD use and attention-deficit/hyperactivity disorder.  Alcohol Health Res World. 1998;  22 127-130
    PubMedGoogle Scholar
  • 21 Biedermann J, Wilens T, Mick E. Is ADHD a risk factor for psychoactive substance use disorder? Findings from a four-year prospective follow-up-study. J Am Child Adolesc Psychiatry 1997 36: 21-29
    Google Scholar
  • 22 Shekim W O, Asarnow R F, Hess E. A clinical and demographic profile of a sample of adults with attention deficit hyperacticity disorder, residual state.  Compr Psychiatry. 1990;  31 416-425
    CrossrefPubMedGoogle Scholar
  • 23 Gittelman R. et al . Hyperactive boys almost grown up: I. Psychiatric status.  Arch Gen Psychiatry. 1985;  42 937-947
    PubMedGoogle Scholar
  • 24 Wilens T E, Biederman J, Mick E. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.  J Nerv Ment Dis. 1997;  185 475-482
    CrossrefPubMedGoogle Scholar
  • 25 Wilens T E, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.  Am J Addict. 1998;  7 156-163
    PubMedGoogle Scholar
  • 26 Wilens T E. Impact of ADHD and its Treatment on Substance Abuse in Adults.  J Clin Psychiatry. 2004;  65 38-45
    PubMedGoogle Scholar
  • 27 Carroll K M. et al . Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.  Arch Gen Psychiatry. 1994;  51 177-187
    PubMedGoogle Scholar
  • 28 Rounsaville B J. et al . Psychiatric diagnoses of treatment-seeking cocaine abusers.  Arch Gen Psychiatry. 1991;  48 43-51
    PubMedGoogle Scholar
  • 29 Carroll K M. et al . History and significance of childhood attention-deficit hyperactivity disorder in treatment-seeking cocaine abusers.  Compr Psychiatry. 1993;  34 75-82
    CrossrefPubMedGoogle Scholar
  • 30 Arnsten A FT. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. Solanto MV, Arnsten AFT, Castellanos FX Stimulant Drugs and ADHD. Basic and Clinical Neuroscience New York; Oxford University Press 2001: 185-208
    Google Scholar
  • 31 Banaschewski T, Brandeis D, Heinrich H. et al . Association of ADHD and conduct disorder - brain electrical evidence for the existence of a distinct subtype.  J Child Psychol Psychiatry. 2003;  44 356-376
    CrossrefPubMedGoogle Scholar
  • 32 Banaschewski T, Brandeis D, Heinrich H. et al . Questioning inhibitory control as the specific deficit of ADHD - evidence from brain electrical activity.  Journal of Neural Transmission Online. 2003; 
    PubMedGoogle Scholar
  • 33 Brandeis D, Banaschewski T, Baving L. et al . Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children.  J Am Acad Child Adolesc Psychiatry. 2002;  41 990-998
    PubMedGoogle Scholar
  • 34 Castellanos F X, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nature reviews.  Neuroscience. 2002;  3 617-628
    CrossrefPubMedGoogle Scholar
  • 35 Faraone S V, Biederman J. Pathophysiology of Attention Deficit Hyperactivity Disorder. Davis K, Charney D, Coyle JT, Nemeroff C ACNP’s Fifth Generation of Progress New York; Lipponcott, Williams and Wilkens 2002: 577-596
    Google Scholar
  • 36 Spencer T, Biederman J, Wilens T. et al . Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle.  J Am Acad Child Adolesc Psychiatry. 1996;  35 409-432
    PubMedGoogle Scholar
  • 37 Gawin F. et al . Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report.  Am J Drug Alc Abuse. 1985;  11 193-197
    PubMedGoogle Scholar
  • 38 Grabowski J, Roache J D, Schmitz J M. Replacement medication for cocaine dependence: methylphenidate.  J Clin Psychopharmacology. 1997;  17 485-488
    CrossrefPubMedGoogle Scholar
  • 39 Wilens T E, Faraone S V, Biederman J. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.  Pediatrics. 2003;  111 179-185
    CrossrefPubMedGoogle Scholar
  • 40 Witcher J W, Long A, Smith B. et al . Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.  J Child Adolesc Psychopharmacol. 2003;  13 53-63
    PubMedGoogle Scholar
  • 41 MTA-Cooperative-Group .A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999 56: 1073-1086
    Google Scholar
  • 42 Kratochvil C J, Heiligenstein J H, Dittmann R. et al . Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.  J Am Acad Child Adolesc Psychiatry. 2002;  41 776-784
    PubMedGoogle Scholar
  • 43 Spencer T, Heiligenstein J H, Biederman J. et al . Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.  J Clin Psychiatry. 2002;  63 1140-1147
    PubMedGoogle Scholar
  • 44 Heil S H, Holmes H W, Bickel W K. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.  Drug Alcohol Depend. 2002;  67 149-156
    CrossrefPubMedGoogle Scholar

Christian Haasen

Klinik für Psychiatrie u. Psychotherapie, Universitätsklinikum Hamburg-Eppendorf

Martinistr. 52

20246 Hamburg

eMail: haasen@uke.uni-hamburg.de

      >